Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03041051

Recruitment Status : Unknown

Verified February 2017 by Vana Spoulou, Aghia Sophia Children's Hospital of Athens.
Recruitment status was: Active, not recruiting

First Posted : February 2, 2017

Last Update Posted : February 2, 2017

Sponsor:

Information provided by (Responsible Party):

Vana Spoulou, Aghia Sophia Children's Hospital of Athens

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	March 1, 2017
Estimated Study Completion Date :	March 2017

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Farmaki PF, Chini MC, Mangafas NM, Tzanoudaki MT, Piperi CP, Lazanas MZ, Spoulou VS. Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults. J Infect Dis. 2018 Jun 5;218(1):26-34. doi: 10.1093/infdis/jiy135.

To Top